Skip to content
U UROLOMAX Istanbul | Medical Tourism Excellence

Uro-Oncology · Istanbul

Bladder Cancer Programme:
from first warning sign to cure — one team, one plan.

Bladder cancer announces itself early — usually as painless blood in the urine — and rewards decisive, expert treatment. Our programme covers the entire arc: blue-light en-bloc resection for early disease, rigorous intravesical protocols, and robotic cystectomy with neobladder reconstruction when the disease demands more.

≈ 0%of cases treated endoscopically — bladder preserved
Blue-lightenhanced visualisation catches tumours white light misses
Neobladdernatural urination restored after robotic cystectomy
Surgical oncology team performing endoscopic bladder tumour resection at a JCI-accredited hospital in Istanbul

The Problem

A cancer that whispers once — then returns.

Painless blood in the urine appears once, disappears, and is dismissed — while the tumour keeps growing. Even when treated, bladder cancer is medicine’s most recurrence-prone malignancy: incomplete piecemeal resections under ordinary white light leave microscopic disease behind, and up to half of patients relapse when surveillance and intravesical therapy are done casually. And when muscle invasion is missed or delayed, the window for cure narrows fast.

The Resolution

Resect completely. Grade honestly. Escalate decisively.

Our surgeons perform en-bloc TUR-BT — lifting the tumour out whole, with its base, under blue-light photodynamic visualisation that makes flat, invisible lesions fluoresce. Pathology receives an intact specimen it can actually stage. Non-muscle-invasive disease then follows a disciplined intravesical BCG or chemotherapy calendar; muscle-invasive disease moves without delay to robotic radical cystectomy — with an orthotopic neobladder rebuilt from your own intestine wherever anatomy and health allow, so life after cure still looks like life.

Two diseases, one name — and why staging is everything.

“Bladder cancer” describes two very different situations. Tumours confined to the inner lining (non-muscle-invasive, ~75% of cases) are treated through the urethra and monitored — the bladder stays. Tumours that have grown into the muscle wall threaten life and demand removal of the organ. The entire strategy hangs on one question: is there muscle in the specimen, and is it invaded? That is why the quality of the first resection decides everything that follows.

When cystectomy is required, the robotic approach means five keyhole ports instead of an open incision: less blood loss, faster bowel recovery, and the precision to protect the nerves and the urethral stump on which a functioning neobladder depends. Our reconstructive surgeons build the new reservoir and retrain it with you — most neobladder patients achieve daytime continence and natural voiding within months.

Every case — early or advanced — is staged and planned by our multidisciplinary tumour board before a single instrument moves.

The programme includes

  • Same-week flexible cystoscopy and CT urography for haematuria work-up.
  • Blue-light en-bloc TUR-BT with immediate post-operative instillation.
  • Structured BCG / intravesical chemotherapy calendars, coordinated with your home urologist.
  • Da Vinci robotic radical cystectomy with orthotopic neobladder or ileal conduit.
  • Lifetime encrypted surveillance schedule — cystoscopy and imaging reminders included.
Request an Oncology Review

From first blood to final answer.

  1. Remote triage — within 48 hours

    Send your symptoms, urine results, or existing cystoscopy report privately. A uro-oncologist maps your diagnostic or treatment pathway before any travel.

  2. Days 1–2 — diagnosis and staging

    Flexible cystoscopy, CT urography, and pre-operative work-up — completed inside 48 hours with your translator at every step.

  3. Day 3 — en-bloc TUR-BT

    Blue-light resection under spinal or general anesthesia; one observed night; immediate single-dose instillation where indicated.

  4. Day 6–7 — pathology, in person

    Full staging pathology explained face to face. Non-muscle-invasive: you fly home with a written intravesical calendar. Muscle-invasive: the tumour board presents your cystectomy and reconstruction plan the same week.

  5. For life — disciplined surveillance

    Bladder cancer is beaten by follow-up as much as by surgery. Your encrypted channel schedules every check, and your surgeon reads every result.

The questions that matter most.

Is blood in the urine always cancer?
No — infections and stones are more common. But painless, visible blood is bladder cancer’s signature warning and must be investigated with cystoscopy and imaging even if it happens once and stops. The patients who do worst are the ones who waited for a second episode.
Will I keep my bladder?
In roughly three out of four cases, yes — the tumour is confined to the lining and treated endoscopically with a rigorous follow-up calendar. When the muscle is invaded, removing the bladder is what removes the danger; reconstruction then restores function.
What does life with a neobladder look like?
Remarkably normal. You urinate through the natural route — no external bag. The new reservoir needs training over the first months, and most patients achieve reliable daytime continence. Where a neobladder is not advisable, a discreet ileal conduit remains a safe, well-lived-with alternative.

One warning sign is enough. So is one message.

Describe what you have noticed, in confidence. A uro-oncologist reviews every message personally within one business day.

Request Discretionary Consultation Precision Diagnostics